Starke 2011.

Methods	Randomised clinical trial, Switzerland
Participants	134 hospitalised adults at nutritional risk according to NRS‐2002 Male:female = not reported Mean age: 72.5 years
Interventions	Experimental group: Individual nutritional care, including a detailed nutritional assessment, individual food supply, fortification of meals with maltodextrin, rapeseed oil, cream or protein powder or both, in between snacks and oral nutritional supplements (n = 67) Control group: Standard nutritional care, including the prescription of ONSs and nutritional therapy prescribed by the physician independently of this study and according to the routine ward management (n = 67)
Outcomes	Average daily intake, protein intake, changes in body weight, complications, antibiotic therapies, length of hospital stay, quality of life, mortality, compliance, plasma‐concentrations
Study dates	Not stated
Notes	We contacted the authors on 17th December 2015 by email: remy.meier@ksli.ch. We received no reply.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	The trial was randomised using a computer‐generated randomisation.
Allocation concealment (selection bias)	Unclear risk	Not described
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Not described
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not described
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The number of participants with incomplete data was not reported.
Selective reporting (reporting bias)	Low risk	Both all‐cause‐mortality and serious adverse events were reported.
For‐profit bias	High risk	The trial was funded by Nestlé.
Other bias	Low risk	The trial appeared to be free of other components that could put it at risk of bias.